Mohammad Bosaeed

840 total citations
52 papers, 373 citations indexed

About

Mohammad Bosaeed is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Mohammad Bosaeed has authored 52 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 22 papers in Epidemiology and 7 papers in Clinical Biochemistry. Recurrent topics in Mohammad Bosaeed's work include COVID-19 Clinical Research Studies (12 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Mohammad Bosaeed is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Mohammad Bosaeed collaborates with scholars based in Saudi Arabia, United States and United Kingdom. Mohammad Bosaeed's co-authors include Deepali Kumar, Ebrahim Mahmoud, Naif Khalaf Alharbi, Adel Alothman, Sameera Al Johani, Omar Aldibasi, Abdullah Algwizani, Yaseen M. Arabi, Sameera Aljohani and Fayssal Farahat and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Mohammad Bosaeed

43 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Bosaeed Saudi Arabia 11 163 158 59 59 32 52 373
Spyridon Karageorgos Greece 12 154 0.9× 93 0.6× 53 0.9× 73 1.2× 51 1.6× 30 427
Roni Bitterman Israel 11 106 0.7× 186 1.2× 62 1.1× 83 1.4× 44 1.4× 27 475
Giorgio Graziano Italy 11 157 1.0× 153 1.0× 42 0.7× 91 1.5× 39 1.2× 35 422
Andrea Bedini Italy 14 287 1.8× 221 1.4× 65 1.1× 68 1.2× 55 1.7× 31 505
Christina Yek United States 10 193 1.2× 114 0.7× 25 0.4× 20 0.3× 18 0.6× 32 407
Kelvin Hei‐Yeung Chiu Hong Kong 11 227 1.4× 103 0.7× 23 0.4× 28 0.5× 9 0.3× 30 466
Alessandra Mularoni Italy 18 264 1.6× 417 2.6× 47 0.8× 132 2.2× 88 2.8× 53 695
Valentijn A. Schweitzer Netherlands 8 124 0.8× 123 0.8× 98 1.7× 26 0.4× 19 0.6× 26 353
Flaminia Olearo Germany 12 234 1.4× 118 0.7× 51 0.9× 96 1.6× 49 1.5× 32 407
Nisha Thampi Canada 13 189 1.2× 154 1.0× 67 1.1× 18 0.3× 22 0.7× 49 410

Countries citing papers authored by Mohammad Bosaeed

Since Specialization
Citations

This map shows the geographic impact of Mohammad Bosaeed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Bosaeed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Bosaeed more than expected).

Fields of papers citing papers by Mohammad Bosaeed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Bosaeed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Bosaeed. The network helps show where Mohammad Bosaeed may publish in the future.

Co-authorship network of co-authors of Mohammad Bosaeed

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Bosaeed. A scholar is included among the top collaborators of Mohammad Bosaeed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Bosaeed. Mohammad Bosaeed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aldayel, Abdulaziz M., Mohammad Bosaeed, Naif Khalaf Alharbi, et al.. (2025). IgM has a better relative distribution in inflammation sites and tumor tissues than IgG. Journal of Nanobiotechnology. 23(1). 253–253. 2 indexed citations
2.
Naeem, Asif, Muhammad Bashir Bello, & Mohammad Bosaeed. (2025). Insights Into Enterovirus D68 Immunology: Unraveling the Mysteries of Host‐Pathogen Interactions. Immunity Inflammation and Disease. 13(2). e70117–e70117. 1 indexed citations
4.
Bosaeed, Mohammad, et al.. (2025). Bacteremia in the Gulf Cooperation Council Region: A Review of the Literature 2013–2023. Infection and Drug Resistance. Volume 18. 2329–2355.
5.
Alzahrani, Mohsen, et al.. (2024). Outcome of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant Recipients. Transplantation Proceedings. 56(1). 186–190.
6.
Alghamdi, Abdullah, Arif Hussain, Ahmed A. Arifi, et al.. (2023). Case Report: COVID-19 Infection of a Transplanted Heart Simulating Cellular Rejection. Transplantation Proceedings. 55(8). 1853–1857.
7.
Johani, Sameera Al, et al.. (2023). Characteristics, Management, and Outcomes of Community-Acquired Pneumonia due to Respiratory Syncytial Virus: A Retrospective Study. Pulmonary Medicine. 2023. 1–8. 6 indexed citations
8.
Saleh, Khalid Bin, Hisham A. Badreldin, Tariq Alqahtani, et al.. (2023). Assessing the influence of COVID-19 on influenza prevalence: A multicenter time series study. Journal of Infection and Public Health. 16(12). 1989–1993. 3 indexed citations
9.
Alharbi, Naif Khalaf, Hind Albalawi, Esam I. Azhar, et al.. (2022). Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels. Vaccines. 10(8). 1330–1330. 6 indexed citations
10.
Bosaeed, Mohammad, et al.. (2022). Characteristics, Management, and Outcomes of Community-Acquired Pneumonia Due to Human Rhinovirus—A Retrospective Study. Canadian Respiratory Journal. 2022. 1–8. 4 indexed citations
11.
Abolfotouh, Mostafa A., et al.. (2022). Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia. BMC Infectious Diseases. 22(1). 950–950. 8 indexed citations
12.
Mahmoud, Ebrahim, Omar Aldibasi, Ahmad M. Alharbi, et al.. (2021). Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia. Journal of Infection and Public Health. 15(1). 36–41. 7 indexed citations
13.
Bosaeed, Mohammad, Ahmad M. Alharbi, Mohammad H. Hussein, et al.. (2021). Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19. BMJ Open. 11(4). e047495–e047495. 5 indexed citations
14.
Bokhari, Yahya, Mohammed Alawad, Ebrahim Mahmoud, et al.. (2021). Early Prediction of COVID-19 Ventilation Requirement and Mortality from Routinely Collected Baseline Chest Radiographs, Laboratory, and Clinical Data with Machine Learning. Journal of Multidisciplinary Healthcare. Volume 14. 2017–2033. 23 indexed citations
15.
Mahmoud, Ebrahim, et al.. (2021). Developing Machine-Learning Prediction Algorithm for Bacteremia in Admitted Patients. Infection and Drug Resistance. Volume 14. 757–765. 18 indexed citations
16.
Mahmoud, Ebrahim, et al.. (2020). <p>Ceftobiprole for Treatment of MRSA Blood Stream Infection: A Case Series</p>. Infection and Drug Resistance. Volume 13. 2667–2672. 16 indexed citations
17.
Mahmoud, Ebrahim, et al.. (2020). Ceftobiprole for Treatment of MRSA Blood Stream Infection: A Case Series. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Mahmoud, Ebrahim, et al.. (2020). Successful treatment of relapsed enterococcal endocarditis with amoxicillin/clavulanate: A case report. IDCases. 19. e00726–e00726. 2 indexed citations
19.
Damlaj, Moussab, Farhan Khalid, Bader Alahmari, et al.. (2020). Optimal pre-emptive cytomegalovirus therapy threshold in a patient population with high prevalence of seropositive status. Current Research in Translational Medicine. 68(3). 131–137. 5 indexed citations
20.
Herrera, Sabina, et al.. (2018). Increased incidence, risk factors, and outcomes of Trichosporon spp bloodstream infections in immunocompromised hosts. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 3(4). 193–201. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026